Compound atlas
Healing

VIP

Also known as · Vasoactive Intestinal Peptide

Peptide
Half-life
0.1h
approx. mean t½
Dose range
50–100 mcg
typical, not prescriptive
Category
Healing
primary use-case
Single-dose decay
t½ = 6m · first-order model
~24m
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m1.2h2.4h3.6h4.8h6h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A signaling peptide studied (often intranasally) for chronic inflammatory response and immune modulation.

Mechanism of action

Activates VPAC receptors with broad anti-inflammatory, vasodilatory, and immune-balancing effects.

Typical protocol

50–100 mcg intranasal several times daily; very short-acting.

Storage

Refrigerated; nasal solution, use promptly.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.